Masimo's long-time lawsuit over Apple Watch patent infringement has encountered another setback, as a U.S. District Court filing reveals the complaint against the USITC will be dismissed with prejudice.
The ITC terminated Masimo's import ban case against Apple's blood oxygen feature on April 17, 2026, clearing redesigned watches after six years of disputes. Apple's iPhone-processing workaround prevails, securing U.S. sales stability.
Apple has been embroiled in a six-year legal battle over one of its Apple Watch health apps. The end may finally be in sight, and here's what Apple has to say about it.
Apple triumphed over Masimo at the ITC, closing a six-year patent battle that threatened Apple Watch blood-oxygen imports. Redesigned feature cleared; full restoration likely soon despite appeals.
From Engadget is a web magazine with obsessive daily coverage of everything new in gadgets and consumer electronics: Apple avoids a second import ban for its redesigned smartwatches in latest court ruling
The ITC terminated its probe into Apple's redesigned Apple Watches, rejecting Masimo's bid to reinstate an import ban over blood-oxygen patents. Apple resumes unrestricted U.S. sales after six years of battles, though appeals remain possible.
